IP Library Granted Patent US 7,645,872
Granted Patent B2
US 7,645,872 · App. 12/535,220 · Granted Jan 12, 2010

Compounds and methods for labeling oligonucleotides

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,645,872
App. No.
12/535,220
Granted
Jan 12, 2010
Kind
B2
Abstract

The invention provides a novel method of labeling oligonucleotides, with reporter moieties, including but not limited to, quenchers, fluorophores, biotin, digoxigenin, peptides and proteins. In addition, this invention provides a method of detecting hybridization of oligonucleotides. This invention also provides novel azo quenchers having the general formula shown below. The invention further provides compositions comprising labeled oligonucleotides and solid supports. The invention also provides kits comprising at least one composition of the present invention.

Claims (8)

1. A composition comprising a quencher linked to a compound selected from the group consisting of an antigen, a steroid, a vitamin, a drug, a hapten, a metabolite, a toxin, an environmental pollutant, an amino acid, a protein, a carbohydrate, a solid support, a linker, and a lipid, wherein the quencher is attached to the compound via an oxime bond.

2. The composition of claim 1 , wherein the composition further comprises a fluorophore.

3. The composition of claim 1 , wherein the quencher is a compound of Formula (I)

wherein R 1-6 are independently selected from the group consisting of an electron withdrawing group, an alkyl group, an aryl group, hydrogen, a heteroaryl group, and a five or six member ring structure formed from the R 1 and R 2 pair, the R 3 and R 4 pair, the R 4 and R 5 pair, or the R 5 and R 6 pair;

R 7 is a substituted or unsubstituted aryl group; and

Y is an oxime forming nucleophile.

4. A kit comprising a composition of claim 1 .

5. The kit of claim 4 , further comprising instructions for the use of the composition.

Assignments (2)
RELEASE OF SECURITY INTEREST Recorded Oct 5, 2017
From: JPMORGAN CHASE BANK, N.A.
To: INTEGRATED DNA TECHNOLOGIES, INC.
Reel/Frame 043800/0186 →
SECURITY AGREEMENT Recorded Apr 26, 2010
From: INTEGRATED DNA TECHNOLOGIES, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 024286/0152 →